Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta

Horm Res. 2007:68 Suppl 5:207-8. doi: 10.1159/000110676. Epub 2007 Dec 10.
No abstract available

MeSH terms

  • Alkaline Phosphatase / blood*
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / therapeutic use
  • Bone Remodeling / drug effects
  • Child
  • Child, Preschool
  • Diphosphonates / administration & dosage*
  • Diphosphonates / therapeutic use
  • Down-Regulation
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Injections, Intravenous
  • Male
  • Osteogenesis Imperfecta / blood*
  • Osteogenesis Imperfecta / drug therapy*
  • Osteogenesis Imperfecta / physiopathology
  • Pamidronate
  • Severity of Illness Index

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Alkaline Phosphatase
  • Pamidronate